ArticleDisease markers2017

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

Paolo Bossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.